Technical Analysis for ATXI - Avenue Therapeutics, Inc.

Grade Last Price % Change Price Change
grade D 5.38 0.94% 0.05
ATXI closed up 0.94 percent on Friday, March 22, 2019, on 15 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Down Down
See historical ATXI trend table...

Date Alert Name Type % Chg
Mar 22 Bollinger Band Squeeze Range Contraction 0.00%
Mar 22 Narrow Range Bar Range Contraction 0.00%
Mar 22 NR7 Range Contraction 0.00%
Mar 22 Inside Day Range Contraction 0.00%
Mar 21 20 DMA Resistance Bearish 0.94%
Mar 21 MACD Bearish Signal Line Cross Bearish 0.94%
Mar 21 180 Bearish Setup Bearish Swing Setup 0.94%
Mar 21 Bollinger Band Squeeze Range Contraction 0.94%
Mar 21 Outside Day Range Expansion 0.94%
Mar 21 Down 3 Days in a Row Weakness 0.94%

Older signals for ATXI ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Avenue Therapeutics, Inc. is a pharmaceutical company. The Company is engaged in acquiring, licensing, developing and commercializing products principally for use in the acute or intensive care hospital setting. Its product candidate is intravenous (IV) Tramadol, an intravenous formulation of tramadol hydrochloride (HCl), for the management of moderate to moderately severe postoperative pain. Tramadol, a synthetic dual-acting opioid, is a centrally acting analgesic with weak opioid agonist properties. It also works via the inhibition of serotonin and noradrenaline re-uptake and blocking nociceptive impulses at the spinal level. Tramadol is also combined with acetaminophen (APAP) or nonsteroidal anti-inflammatory drugs (NSAIDS) in clinical practice. During the year ending December 31, 2016, the Company had completed a pharmacokinetics (PK) study for IV Tramadol in healthy volunteers.
Pharmaceutical Drugs Chemical Compounds Pharmacokinetics Analgesics Neurochemistry Hepatotoxins Amines Opioid Paracetamol
Is ATXI a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 2 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 6.82
52 Week Low 2.08
Average Volume 46,642
200-Day Moving Average 4.4449
50-Day Moving Average 5.7528
20-Day Moving Average 5.4885
10-Day Moving Average 5.551
Average True Range 0.3194
ADX 13.25
+DI 10.9938
-DI 13.2507
Chandelier Exit (Long, 3 ATRs ) 4.9318
Chandelier Exit (Short, 3 ATRs ) 6.0782
Upper Bollinger Band 5.8154
Lower Bollinger Band 5.1616
Percent B (%b) 0.33
BandWidth 11.91218
MACD Line -0.0527
MACD Signal Line -0.0446
MACD Histogram -0.0081
Fundamentals Value
Market Cap 54.02 Million
Num Shares 10 Million
EPS -0.44
Price-to-Earnings (P/E) Ratio -12.23
Price-to-Sales 0.00
Price-to-Book 1.57
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.60
Resistance 3 (R3) 5.59 5.50 5.57
Resistance 2 (R2) 5.50 5.44 5.51 5.55
Resistance 1 (R1) 5.44 5.41 5.40 5.45 5.54
Pivot Point 5.35 5.35 5.33 5.36 5.35
Support 1 (S1) 5.29 5.29 5.25 5.31 5.22
Support 2 (S2) 5.20 5.26 5.21 5.21
Support 3 (S3) 5.14 5.20 5.19
Support 4 (S4) 5.16